Reduced incidence of diabetes during the COVID-19 pandemic in Alberta: A time-segmented longitudinal study of Alberta's Tomorrow Project.
cohort study
database research
observational study
population study
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
22 Dec 2023
22 Dec 2023
Historique:
revised:
30
11
2023
received:
11
09
2023
accepted:
30
11
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
22
12
2023
Statut:
aheadofprint
Résumé
To characterize the impact of the COVID-19 pandemic on diabetes diagnosis using data from Alberta's Tomorrow Project (ATP), a population-based cohort study of chronic diseases in Alberta, Canada. The ATP participants who were free of diabetes on 1 April 2018 were included in the study. A time-segmented regression model was used to compare incidence rates of diabetes before the COVID-19 pandemic, during the first two COVID-19 states of emergency, and in the period when the state of emergency was relaxed, after adjusting for seasonality, sociodemographic factors, socioeconomic status, and lifestyle behaviours. Among 43 705 ATP participants free of diabetes (65.5% females, age 60.4 ± 9.5 years in 2018), the rate of diabetes was 4.75 per 1000 person-year (PY) during the COVID-19 pandemic (up to 31 March 2021), which was 32% lower (95% confidence interval [CI] 21%, 42%; p < 0.001) than pre-pandemic (6.98 per 1000 PY for the period 1 April 2018 to 16 March 2020). In multivariable regression analysis, the first COVID-19 state of emergency (first wave) was associated with an 87.3% (95% CI -98.6%, 13.9%; p = 0.07) reduction in diabetes diagnosis; this decreasing trend was sustained to the second COVID-19 state of emergency and no substantial rebound (increase) was observed when the COVID-19 state of emergency was relaxed. The COVID-19 public health emergencies had a negative impact on diabetes diagnosis in Alberta. The reduction in diabetes diagnosis was likely due to province-wide health service disruptions during the COVID-19 pandemic. Systematic plans to close the post-COVID-19 diagnostic gap are required in diabetes to avoid substantial downstream sequelae of undiagnosed disease.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Alberta Cancer Foundation
Organisme : Alberta Health
Organisme : Canadian Partnership Against Cancer
Organisme : Health Canada
Informations de copyright
© 2023 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Références
Coronavirus Disease (COVID-19): Epidemiology Update. Government of Canada; 2023.
Alberta Health Services. Information for Albertans-novel coronavirus. 2020 https://www.albertahealthservices.ca/topics/Page16997.aspx#social. Accessed March 30, 2020.
Government of Alberta. Chief Medical Officer of Health order: 2020 COVID-19 response. 2020 https://open.alberta.ca/dataset?q=&sort=metadata_created+desc&pubtype=Orders+and+Directives&tags=COVID-19. Accessed July 14, 2020.
Alberta Health Services. Information for Albertans: Novel coronavirus (COVID-19). 2020 https://www.albertahealthservices.ca/topics/Page16997.aspx#social. Accessed July 14, 2020.
Services AH, ed. Information for AHS Staff & Health Professionals-he novel coronavirus (COVID-19). 2020.
Canadian COVID-19 Intervention Timeline. Canadian Institute of Health Information; 2022.
Mandel E, Peci A, Cronin K, et al. The impact of the first, second and third waves of covid-19 on hepatitis B and C testing in Ontario, Canada. J Viral Hepat. 2022;29(3):205-208.
Frankfurter C, Buchan TA, Kobulnik J, et al. Reduced rate of hospital presentations for heart failure during the COVID-19 pandemic in Toronto, Canada. Can J Cardiol. 2020;36(10):1680-1684.
Heer E, Ruan Y, Boyne DJ, et al. Impact of the COVID-19 pandemic on cancer diagnoses, stage and survival in Alberta. CMAJ. 2023;195(23):E804-E812.
Tsai HY, Chou YJ, Pu C. Continuity of care trajectories and emergency room use among patients with diabetes. Int J Public Health. 2015;60(4):505-513.
Weir DL, McAlister FA, Majumdar SR, Eurich DT. The interplay between continuity of care, multimorbidity, and adverse events in patients with diabetes. Med Care. 2016;54(4):386-393.
Herman WH, Ye W, Griffin SJ, et al. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449-1455.
Jin J. Screening for prediabetes and type 2 diabetes. JAMA. 2021;326(8):778.
Kenealy T, Elley CR, Arroll B. Screening for diabetes and prediabetes. Lancet. 2007;370(9603):1888-1889.
Ye M, Robson PJ, Eurich DT, Vena JE, Xu JY, Johnson JA. Cohort profile: Alberta's tomorrow project. Int J Epidemiol. 2016;46:1097-1098l.
Csizmadi I, Kahle L, Ullman R, et al. Adaptation and evaluation of the National Cancer Institute's diet history questionnaire and nutrient database for Canadian populations. Public Health Nutr. 2007;10(1):88-96.
Friedenreich CM, Courneya KS, Neilson HK, et al. Reliability and validity of the past year Total physical activity questionnaire. Am J Epidemiol. 2006;163(10):959-970.
Canada PHAo. Report from the National Diabetes Surveillance System: Diabetes in Canada, 2009. 2009.
Mathe N, Ryan A, Cook A, et al. Enhancing diabetes surveillance across Alberta by adding laboratory and pharmacy data to the National Diabetes Surveillance System Methods. Can J Diabetes. 2021;46:375-380.
Armitage PBG, Matthews J. Statistical Methods in Medical Research. John Wiley and Sons; 2008.
Senapati A, Nag A, Mondal A, Maji S. A novel framework for COVID-19 case prediction through piecewise regression in India. Int J Inf Technol. 2021;13(1):41-48.
Gomez YM, Gallardo DI, Leao J, Calsavara VF. On a new piecewise regression model with cure rate: diagnostics and application to medical data. Stat Med. 2021;40(29):6723-6742.
Brown AF, Mangione CM, Saliba D, Sarkisian CA. California healthcare foundation/American Geriatrics Society panel on improving Care for Elders with D. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265-S280.
Garriguet D. Diet quality in Canada. Health Rep. 2009;20(3):41-52.
Solbak NM, Xu JY, Vena JE, Csizmadi I, Whelan HK, Robson PJ. Diet quality is associated with reduced incidence of cancer and self-reported chronic disease: observations from Alberta's tomorrow project. Prev Med. 2017;101:178-187.
Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK. Lancet Diabetes Endocrinol. 2021;9(7):413-415.
Chudasama YV, Gillies CL, Zaccardi F, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020;14(5):965-967.
Inglin L, Wikstrom K, Lamidi ML, Laatikainen T. The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland. BMC Health Serv Res. 2022;22(1):725.
Zhang YN, Chen Y, Wang Y, et al. Reduction in healthcare services during the COVID-19 pandemic in China. BMJ Glob Health. 2020;5(11):e003421.
Holland D, Heald AH, Stedman M, et al. Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis. J Clin Pathol. 2023;76(3):177-184.
Amsah N, Md Isa Z, Ahmad N, Abdul Manaf MR. Impact of COVID-19 pandemic on healthcare utilization among patients with type 2 diabetes mellitus: a systematic review. Int J Environ Res Public Health. 2023;20(5):4577.
Wild SH, Byrne CD. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ. 2006;333(7576):1009-1011.
Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2017;46(1):348-355.
Turner SL, Karahalios A, Forbes AB, et al. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020;122:1-11.
Tierney JF, Fisher DJ, Burdett S, Stewart LA, Parmar MKB. Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: an observational study. PLoS Med. 2020;17(1):e1003019.
Hardt PD, Brendel MD, Kloer HU, Bretzel RG. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008;31(Suppl 2):S165-S169.
Stone MA, Camosso-Stefinovic J, Wilkinson J, de Lusignan S, Hattersley AT, Khunti K. Incorrect and incomplete coding and classification of diabetes: a systematic review. Diabetic Med. 2010;27(5):491-497.
Leslie RD, Evans-Molina C, Freund-Brown J, et al. Adult-onset type 1 diabetes: current understanding and challenges. Diabetes Care. 2021;44(11):2449-2456.